Publications
Specialty
Search
Oncology
06/20/2024
Erika Hamilton, MD discusses the long-term analysis from the phase 3 DESTINY-Breast03 trial which reinforced the superiority of trastuzumab deruxtecan over trastuzumab emtansine for patients with HER2-positive metastatic breast cancer previously treated with ≥1 anti-HER2 regimen.
Psych Congress Network
06/20/2024
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Annals of Long-Term Care, Neurology
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Oncology
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
Oncology
06/20/2024
In this video, a panel of experts highlight 8-year updated results from the APHINITY trial and reflect on the progress that has been made in the setting of HER2-positive breast cancer.
Oncology
06/20/2024
In this video, our experts explore therapy options for patients with high-risk HER2-positive breast cancer, sharing their views on anthracycline-based therapies, neratinib, and immunotherapy for these patients, and discussing data from the KATHERINE trial.
Oncology
06/20/2024
In this video, a panel of experts discuss the management of patients with stage 1, HER2-positive breast cancer, sharing data from several trials in this space, including the APT, ADEPT, and ATEMPT 2.0 trials.
Oncology
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
06/20/2024
This innovative augmented reality-based interventional radiology suite combines a holographic heads-up display streaming live medical imaging, 3D anatomy model visualization and advanced imaging technologies, while enabling the opportunity for remote collaboration to help advance the delivery of precision care across a variety of interventional procedures.
Oncology
06/20/2024
In this video, a panel of experts discuss approaches to neoadjuvant and adjuvant therapy for early-stage HER2-positive breast cancer and the value of achieving a pathological complete response from the surgical and medical oncology perspectives.
Oncology
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, explores whether or not there is a role for immune therapy in the treatment of patients with proficient mismatch repair colorectal cancer.
Oncology
06/20/2024
Jennifer Eads, MD, comments on the results from the ESOPEC trial, which found perioperative chemotherapy improved survival for patients with resectable esophageal adenocarcinoma when compared with neoadjuvant chemoradiation.
Dermatology
06/20/2024
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
The Dermatologist
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
The Dermatologist
06/20/2024
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
EMSWorld
06/20/2024
The program, Operation1Stride, is a six-week equine-assisted therapy (EAT) program designed to empower first responders to lead horses and build trust and connection to help improve their overall well-being.
EMSWorld
06/20/2024
New data shows opioid-related overdose deaths increased by 12% in Boston, even though the Massachusetts Department of Public Health reported a 10% decrease statewide.
Advances in Inflammatory Bowel Disease Network, Gastroenterology, APP Institute Inflammatory Bowel Disease
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
Oncology
06/20/2024
The addition of low-dose nivolumab to triple metronomic chemotherapy significantly improved overall survival among patients with relapsed, recurrent, or newly diagnosed advanced head and neck squamous cell carcinoma.
Oncology
06/20/2024
Primary analysis results from the phase 2 WU-KONG1 study found that sunvozertinib demonstrated promising anti-tumor efficacy and safety among patients with platinum pre-treated locally advanced or metastatic non-small cell lung cancer harboring EGFR exon20ins mutations.